Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Paul T. Gellhaus"'
Publikováno v:
Urology Case Reports, Vol 38, Iss , Pp 101695- (2021)
Neurofibromatosis 1 is a relatively rare genetic disease characterized by widespread neurofibromas originating from the peripheral nervous system. Most growths are benign, but some carry a risk of transformation to malignant peripheral nerve sheath t
Externí odkaz:
https://doaj.org/article/295f32d57080422489786944f3a34317
Autor:
Mark D. Bevill, Justin N. Drobish, Kevin J. Flynn, Maheen Rajput, Catherine Metz, Chad R. Tracy, Paul T. Gellhaus
Publikováno v:
Current Urology.
Autor:
Ian M. McElree, Ryan L. Steinberg, Alex C. Martin, Jordan Richards, Sarah L. Mott, Paul T. Gellhaus, Kenneth G. Nepple, Michael A. O'Donnell, Vignesh T. Packiam
Publikováno v:
The Journal of urology. 208(3)
Bacillus Calmette-Guérin (BCG) is currently recommended as adjuvant therapy following complete transurethral resection of bladder tumor for high-risk nonmuscle-invasive bladder cancer (NMIBC). In response to the BCG shortage, gemcitabine plus doceta
Autor:
Ian M. McElree, Vignesh T. Packiam, Ryan L. Steinberg, Sarah L. Mott, Paul T. Gellhaus, Kenneth G. Nepple, Michael A. O'Donnell
Publikováno v:
The Journal of urology. 208(5)
Intravesical gemcitabine-docetaxel has emerged as an efficacious and well-tolerated salvage therapy for non-muscle-invasive bladder cancer. However, further rescue therapies are needed for subsequent recurrences or intolerance, particularly when cyst
Autor:
Ian M. McElree, Vignesh T. Packiam, Ryan L. Steinberg, Sarah L. Mott, Paul T. Gellhaus, Kenneth G. Nepple, Michael A. O'Donnell
Publikováno v:
Journal of Urology. 207
Autor:
Phani T. Chevuru, Ian M. McElree, Alexander C. Martin, Jordan R. Richards, Sarah L. Mott, Paul T. Gellhaus, Kenneth G. Nepple, Ryan L. Steinberg, Michael A. O'Donnell, Vignesh T. Packiam
Publikováno v:
Journal of Urology. 207
Autor:
Ian M. McElree, Ryan L. Steinberg, Alex C. Martin, Jordan Richards, Sarah L. Mott, Paul T. Gellhaus, Kenneth G. Nepple, Michael A. O'Donnell, Vignesh T. Packiam
Publikováno v:
Journal of Urology. 208:599-600
Publikováno v:
Translational andrology and urology. 11(9)
Androgen deprivation therapy (ADT) remains a cornerstone of treatment for advanced prostate cancer. Few men elect for surgical castration via bilateral orchiectomy. We sought to compare the relative difference in financial charges between chemical an
Autor:
Ian Mitchell McElree, Ryan L. Steinberg, Sarah L. Mott, Alexander C. Martin, Jordan Richards, Paul T. Gellhaus, Kenneth G. Nepple, Michael A. O'Donnell, Vignesh T. Packiam
Publikováno v:
Journal of Clinical Oncology. 40:497-497
497 Background: Bacillus Calmette-Guerin (BCG) is currently recommended as adjuvant therapy following complete transurethral resection of bladder tumor (TURBT) for high-risk non-muscle invasive bladder cancer (NMIBC). However, continued BCG productio
Autor:
Ian Mitchell McElree, Vignesh T. Packiam, Ryan L. Steinberg, Sarah L. Mott, Paul T. Gellhaus, Kenneth G. Nepple, Michael A. O'Donnell
Publikováno v:
Journal of Clinical Oncology. 40:496-496
496 Background: Intravesical gemcitabine-docetaxel (Gem/Doce) has emerged as an efficacious and well-tolerated therapy for NMIBC. At first cytoscopic evaluation, success rate for BCG failures is 75-80% with 60% of responders remaining disease free at